A possible role for BDNF, NT-4 and TrkB in the spinal cord and muscle of rat subjected to mechanical overload, bupivacaine injection and axotomy.
Neurotrophins play a crucial role in the regulation of survival and the maintenance of specific functions for various populations of neurons. Neurotrophin-4 (NT-4) is most abundant in skeletal muscle, and is thought to promote sciatic nerve sprouting, inhibit agrin-induced acetylcholine receptor (AChR) clustering, evoke postsynaptic potentiation and induce mitochondrial proliferation. Using Western blot analysis, immunoprecipitation and immunohistochemistry, we investigated the distribution of NT-4 in slow- and fast-type muscles. We also tested the adaptive response of this protein in the mechanically overloaded muscle, in the regenerating muscle following bupivacaine injection and in the denervated muscle. Additionally, we investigated whether TrkB phosphorylation in the spinal cord and in the sciatic nerve occurs through the interaction with BDNF or NT-4 when the innervating muscle is damaged. Markedly more NT-4 was expressed in fast-type muscles compared with the slow types. TrkB protein was more frequently observed around the edge of myofibers (neuromuscular junction) of the soleus muscle compared with the gastrocnemius muscle. TrkB tyrosine phosphorylation occurred in the spinal cord but not in the sciatic nerve 24 h after bupivacaine injection of the innervating muscle. At the same time, the amount of TrkB co-precipitating with BDNF was markedly increased in the spinal cord. A rapid activation of TrkB (1-8 h) was also observed in the spinal cord after axotomy,while the amount of TrkB co-precipitating with NT-4 was markedly lower after axotomy. These results indicate that NT-4 is preferentially distributed in fast-type muscles. Furthermore, by interacting with BDNF and NT-4, the TrkB in the spinal cord may be important for the survival of motoneurons and outgrowth of injured peripheral axons following muscle damage.
Sakuma
K
K
Department of Legal Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-hirokoji, Kamigyo-ku, 602-8566, Kyoto, Japan. ksakuma@basic.kpu-m.ac.jp
Watanabe
K
K
Sano
M
M
Uramoto
I
I
Nakano
H
H
Li
Y J
YJ
Kaneda
S
S
Sorimachi
Y
Y
Yoshimoto
K
K
Yasuhara
M
M
Totsuka
T
T
D000818:Animals; D019771:Axotomy; D019208:Brain-Derived Neurotrophic Factor / Q000502:physiology*; D002045:Bupivacaine / Q000633:toxicity*; D002470:Cell Survival; D005260:Female; D008297:Male; D009046:Motor Neurons / Q000473:pathology; D009121:Muscle Denervation; D018656:Muscle Fibers, Fast-Twitch / Q000378:metabolism; D018657:Muscle Fibers, Slow-Twitch / Q000378:metabolism; D009124:Muscle Proteins / Q000502:physiology*; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology / Q000601:surgery; D009414:Nerve Growth Factors / Q000502:physiology*; D009419:Nerve Tissue Proteins / Q000502:physiology*; D009928:Organ Specificity; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D051381:Rats; D017208:Rats, Wistar; D020813:Receptor, trkB / Q000502:physiology*; D012038:Regeneration / Q000187:drug effects / Q000502:physiology*; D012584:Sciatic Nerve / Q000293:injuries; D013119:Spinal Cord Injuries / Q000378:metabolism / Q000503:physiopathology*; D016474:Weight-Bearing
D019208:Brain-Derived Neurotrophic Factor; D009124:Muscle Proteins; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D020813:Receptor, trkB; C073922:neurotrophin 4; D002045:Bupivacaine